Skip to main content

The Stress Response of Critical Illness: Which Is the Role of Sedation?

  • Chapter
  • First Online:
Critical Care Sedation

Abstract

Trauma, surgery, and infection represent a common source of stress in critically ill patients admitted in intensive care units (ICUs). Although the consequences of stress response in critical illness are still debated and not well understood, many neural and hormonal responses have been recognized to activate homeostatic mechanisms aimed at favoring survival and healing. These responses develop toward three different phases: the first immediate and short (24 h) phase, termed ebb, is directed to immediate survival; the second longer phase (6–7 days), termed flow, is characterized by an increase in total body oxygen consumption and carbon dioxide production with hypermetabolism; the third phase, termed chronic, may last some months and identifies the post-stress period of critical illness. Although the effects of sedatives (analgesics and hypnotics) on tissue metabolic demand of critically ill patient remain difficult to be adequately defined, these drugs commonly delivered in intensive care units actually influence the stress response by decreasing neurohumoral reactions, involving the sympathetic system, and affecting the inflammatory mechanisms. After the neuroendocrine activation, uncontrolled metabolic reactions, characterized by catabolism and the resistance to anabolic signals as insulin, develop. Secondary negative effects (infections, muscle atrophy and weakness, respiratory insufficiency, delayed wound healing) can occur as direct consequences of metabolic phenomena that are clearly difficult to monitor. Finally, sedatives administered to control stress response clearly have detrimental effects (hemodynamic alterations, immunosuppression, delirium) that should be carefully evaluated in the context of a balance between benefits and damages.

“Today there is a greater and growing awareness of the need to understand the disturbed metabolism and homeostatic mechanisms which come into play when man is injured, whether by accident or surgery, and how these reactions may be assisted in relation to improving the patient’s condition.”

D. P. Cuthbertson, 1975

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Institutional subscriptions

References

  1. Cuthbertson DP. Observations on the disturbances of metabolism produced by injury to the limbs. Q J Med. 1932;4:233–44.

    Google Scholar 

  2. Moore FD, Olsen KH, McMurray JD. The body cell mass and its supporting environment. Philadelphia: W B Saunders; 1978.

    Google Scholar 

  3. Kohl BA, Deutschman CS. The inflammatory response to surgery and trauma. Curr Opin Crit Care. 2006;12:325–32.

    Article  PubMed  Google Scholar 

  4. Preiser JC, Ichal C, Orban C, et al. Metabolic response to the stress of critical illness. Br J Anaesth. 2014;6:945–54.

    Article  Google Scholar 

  5. Kumba C, Van der Linden P. Effects of sedative agents on metabolic demand. Ann Fr Anesth Reanim. 2008;27:574–80.

    Article  CAS  PubMed  Google Scholar 

  6. Kurosawa S, Kato M. Anesthetics, immune cells, and immune responses. J Anesth. 2008;22:263–77.

    Article  PubMed  Google Scholar 

  7. Beishuizen A, Thijs LG. The immunoneuroendocrine axis in critical illness: beneficial adaptation or neuroendocrine exhaustion? Curr Opin Crit Care. 2004;10:461–7.

    Article  PubMed  Google Scholar 

  8. Van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in critically ill patients. N Engl J Med. 2001;345:1359–67.

    Article  PubMed  Google Scholar 

  9. Weelers F, Giulietti AP, Michalad M, et al. Metabolic, endocrine immune effects of stress hyperglycemia in a rabbit model of prolonged critical illness. Endocrinology. 2003;44:329–38.

    Google Scholar 

  10. Gotts JE, Matthay MA. Sepsis: pathophysiology and clinical management. BMJ. 2016;353:i1585.

    Article  PubMed  Google Scholar 

  11. Nematy M, Brynes AE, Hornick PI, et al. Postprandial ghrelin suppression is exaggerated following major surgery; implications for nutritional recovery. Nutr Metab. 2007;4:20–2.

    Article  Google Scholar 

  12. Forceville X, Vitoux D, Gauzit R, et al. Selenium, systemic immune response syndrome, sepsis, and outcome in critically ill patients. Crit Care Med. 1998;26:1536–44.

    Article  CAS  PubMed  Google Scholar 

  13. Presier JC, van Zanten A, Berger MM, et al. Metabolic and nutritional support of critically ill patients: consensus and controversies. Crit Care. 2015;19:35–46.

    Article  Google Scholar 

  14. Casaer MP, Mesotten D, Hermans G, et al. Early versus late parenteral nutrition in critically ill adults. N Engl J Med. 2011;365:506–17.

    Article  CAS  PubMed  Google Scholar 

  15. Turina M, Fry DE, Polk HC Jr. Acute hyperglycemia and the innate immune system: clinical, cellular, and molecular aspects. Crit Care Med. 2005;33:1624–33.

    Article  PubMed  Google Scholar 

  16. Brownlee M. The pathobiology of diabetic complications: a unifying mechanism. Diabetes. 2005;54:1615–25.

    Article  CAS  PubMed  Google Scholar 

  17. Weekers F, Giulietti AP, Michalaki M, et al. Metabolic, endocrine, and immune effects of stress hyperglycemia in rabbit model of prolonged critical illness. Endocrinology. 2003;144:329–38.

    Article  Google Scholar 

  18. Hansen TK, Thiel S, Wouters PJ, et al. Intensive insulin therapy exerts antiinflammatory effects in critically ill patients and counteracts the adverse effect of low mannose-binding lectin levels. J Clin Endocrinol Metab. 2003;88:1082–9.

    Article  CAS  PubMed  Google Scholar 

  19. Vlasselaers D, Milants I, Desmet L, et al. Intensive insulin therapy for patients in paediatric intensive care: a prospective, randomised controlled study. Lancet. 2009;373:547–56.

    Article  CAS  PubMed  Google Scholar 

  20. Ellger B, Debaveye Y, Vanhorebeek I, et al. Survival benefits of intensive insulin therapy in critical illness: impact of maintaining normoglycemia versus glycemia-independent actions of insulin. Diabetes. 2006;55:1096–105.

    Article  CAS  PubMed  Google Scholar 

  21. Puthucheary ZA, Rawal J, McPhail M, et al. Acute skeletal muscle wasting in critical illness. JAMA. 2013;310:1591–600.

    Article  CAS  PubMed  Google Scholar 

  22. McClave SA, Martindale RG, Kiraly L. The use of indirect calorimetry in the intensive care unit. Curr Opin Clin Nutr Metab Care. 2013;16:202–8.

    Article  CAS  PubMed  Google Scholar 

  23. Vincent JL, Preiser JC. When should we add parenteral to enteral nutrition? Lancet. 2013;381:354–5.

    Article  PubMed  Google Scholar 

  24. Heidegger CP, Berger MM, Graf S, et al. Optimisation of energy provision with supplemental parenteral nutrition in critically ill patients: a randomised controlled clinical trial. Lancet. 2013;381:385–93.

    Article  PubMed  Google Scholar 

  25. Dungan KM, Braithwaite SS, Preiser JC. Stress hyperglycemia. Lancet. 2009;373:1798–807.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Mistraletti G, Donatelli F, Carli F. Metabolic and endocrine effects of sedative agents. Curr Opin Crit Care. 2005;11:312–7.

    Article  PubMed  Google Scholar 

  27. Barr J, Fraser GL, Puntillo K, et al. Clinical practice guidelines for the management of pain, agitation, and delirium in adult patients in the intensive care unit. Crit Care Med. 2013;41:263–306.

    Article  PubMed  Google Scholar 

  28. Chen L, Meng K, Su W, et al. The effect of continuous sedation therapy on immunomodulation, plasma levels of antioxidants and indicators of tissue repairs in post-burn sepsis. Cell Biochem Biophys. 2015;73:473–8.

    Article  CAS  PubMed  Google Scholar 

  29. Porhomayon J, El-Solh AA, Adiparvar G, et al. Impact of sedation on cognitive function in mechanically ventilated patients. Lung. 2016;194:43–52.

    Article  CAS  PubMed  Google Scholar 

  30. Barrett JE, Haas DA. Perspectives and trends in pharmacological approaches to the modulation of pain. Adv Pharmacol. 2016;75:1–33.

    Article  PubMed  Google Scholar 

  31. Hughes CG, McGrane S, Pandharipande P. Sedation in the intensive care setting. Clin Pharmacol. 2012;4:53–63.

    PubMed  PubMed Central  Google Scholar 

  32. Marana E, Russo A, Colicci S, et al. Desflurane versus sevoflurane: a comparison on stress response. Minerva Anestesiol. 2013;79:7–14.

    CAS  PubMed  Google Scholar 

  33. Marana E, Annetta MG, Meo F, et al. Sevoflurane improves the neuroendocrine stress response during laparoscopic pelvic surgery. Can J Anaesth. 2003;50(4):348–54.

    Article  PubMed  Google Scholar 

  34. Soukup J, Selle A, Wienke A, Steighardt J, et al. Efficiency and safety of inhalative sedation with sevoflurane in comparison to an intravenous sedation concept with propofol in intensive patients: study protocol for a randomized controlled trial. Trials. 2012;13:135–42.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to A. Raffaele De Gaudio .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG

About this chapter

Cite this chapter

De Gaudio, A.R., Bonifazi, M., Romagnoli, S. (2018). The Stress Response of Critical Illness: Which Is the Role of Sedation?. In: De Gaudio, A., Romagnoli, S. (eds) Critical Care Sedation. Springer, Cham. https://doi.org/10.1007/978-3-319-59312-8_2

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-59312-8_2

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-59311-1

  • Online ISBN: 978-3-319-59312-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics